Nutritional Status Indicators as a Predictor of Achieving Remission at Week 14 during Vedolizumab Therapy in Patients with Ulcerative Colitis: A Pilot Study

Background: The loss of response or failure to achieve remission to vedolizumab in ulcerative colitis (UC) patients is currently a major clinical problem. Recently, Nutritional Risk Index (NRI), Controlling Nutritional Status (CONUT), and Malnutrition Universal Screening Tool (MUST) have been sugges...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobolewska-Włodarczyk, Aleksandra, Walecka-Kapica, Ewa, Włodarczyk, Marcin, Gąsiorowska, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824159/
https://www.ncbi.nlm.nih.gov/pubmed/36615897
http://dx.doi.org/10.3390/nu15010240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824159/
https://www.ncbi.nlm.nih.gov/pubmed/36615897
http://dx.doi.org/10.3390/nu15010240

Ejemplares similares